AFMD
Affimed NV
NASDAQ: AFMD · HEALTHCARE · BIOTECHNOLOGY
$0.18
+0.00% today
Updated 2026-04-29
Market cap
$2.98M
P/E ratio
—
P/S ratio
0.53x
EPS (TTM)
$-5.09
Dividend yield
—
52W range
$0 – $1
Volume
23.5M
Affimed NV (AFMD) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-8.64M | $-5.68M | $-10.55M | $-18.54M | $-32.13M | $-25.55M | $49.44M | $-29.06M | $-19.40M | $-86.59M | $-104.89M | $-110.27M |
| Capital expenditures | $35000.00 | $162000.00 | $305000.00 | $277000.00 | $259000.00 | $668000.00 | $721000.00 | $1.47M | $440000.00 | $3.85M | $696000.00 | $3.73M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $1.92M | $17000.00 | $-4.89M | $2.22M | $3.54M | $1.94M | $2.04M | $2.47M | $3.38M | $11.82M | $19.11M | $10.71M |
| Free cash flow | $-8.68M | $-5.84M | $-10.85M | $-18.81M | $-32.39M | $-26.22M | $48.72M | $-30.53M | $-19.84M | $-90.44M | $-105.59M | $-114.00M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — |